21/48US=47 / Clín/Medica
Candore G, Balistreri CR, Campagna AM, Colombo A, Cuppari I, Di-Carlo D, Grimaldi MP, Orlando V, Piazza G, Vasto S, Lio D, Caruso C. Genetic control of immune response in carriers of ancestral haplotype 8.1: the study of chemotaxis. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 509-15. ISBN 978-1-57331-699-5.

ESTUDO DA QUIMIOTAXIA; HAPLOTIPO ANCESTRAL; DOENCA AUTO-IMUNE; QUIMIOTAXIA; HLA; RESPOSTA IMUNE

22/48US=47 / Clín/Medica
Candore G, Balistreri CR, Listi F, Grimaldi MP, Vasto S, Lolonna-Romano G, Franceschi C,Lio D, Caselli G, Caruso C. Immunogenetics, gender, and longevity. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 516-37. ISBN 978-1-57331-699-5.

IMUNOGENETICA; GENERO; ENVELHECIMENTO; RESPOSTA IMUNE; INFLAMACAO; LONGEVIDADE

23/48US=47 / Clín/Medica
Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH. Estrogens and autoimmune disease. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 538-47. ISBN 978-1-57331-699-5.

IMUNOGENETICA; GENERO; ENVELHECIMENTO; RESPOSTA IMUNE; INFLAMACAO; LONGEVIDADE

24/48US=47 / Clín/Medica
Ponzone R, Biglia N, Jacomuzzi ME, Mariani L, Dominguez A, Sismondi P. Antihormones in prevention and treatment of breast cancer. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 143-58. ISBN 978-1-57331-699-5.

ESTROGENIOS; DOENCA AUTO-IMUNE; MAMA; CANCER; ENDOCRINO; TRATAMENTO; PREVENCAO

25/48US=47 / Clín/Medica
Traina A, Agostara B, Marasa L, Calabro M, Zarcone M, Carruba G. HER2/neu expression. in relation to clinicopathologic features of breast câncer patients. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 159-67. ISBN 978-1-57331-699-5.

HER2/NEU; CANCER DE MAMA; ANALISE DE SOBREVIDA GLOBAL

26/48US=47 / Clín/Medica
Bosland MC. Sex steroids and prostate carcinogenesis integrated, multifactorial working hypothesis. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 168-76. ISBN 978-1-57331-699-5.

ESTEROIDES SEXUAIS; CARCINOGENESE DA PROSTATA INTEGRADO; PROSTATA; CANCER DE PROSTATA; ESTROGENIO; ANDROGENO; CARCINOGENESE; HORMONAL CARCINOGENESE

27/48US=47 / Clín/Medica
Ho SM, Leung YK, Chung I. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 177-93. ISBN 978-1-57331-699-5.

ESTROGENIOS; ANTIESTROGENIOS; RECEPTOR DE ESTROGENO; ANTIESTROGENS; MODULADOR SELETIVO. RECEPTOR DE ESTROGENO; COREGULATORS RECEPTORES NUCLEARES; METILACAO DO DNA; ALCACUZ; APIGENINA; ESTRESSE OXIDATIVO; RISCO DE CANCER DE PROSTATA; TERAPIA HORMONAL

28/48US=47 / Clín/Medica
Migliaccio A, Castoria G, Di Domenico M, Ciociola A, Lombardi M, Falco A, Nanayakkara M, Bottero D, Stasio R, Varricchio L, Auricchio F. Crosstalk between EGFR and extranuclear steroid receptors. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 194-200. ISBN 978-1-57331-699-5.

DIAFONIA ENTRE O EGFR; RECEPTORES DE ESTEROIDES EXTRANUCLEARES; RECEPTOR DE ANDROGENO; RECEPTOR DE ESTROGENO; TRANSDUCAO DE SINAL; FATOR DE CRESCIMENTO EPIDERMICO

29/48US=47 / Clín/Medica
Carruba G. Estrogens and mechanisms of prostate cancer progression. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 201-17. ISBN 978-1-57331-699-5.

ESTROGENIOS; METABOLISMO; RECEPTOR; CANCER DE PROSTATA; PROGRESSAO

30/48US=47 / Clín/Medica
Harkonen PL, Vaananen HK. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 218-27. ISBN 978-1-57331-699-5.

ESTROGENIO; RECEPTOR DE ESTROGENO; MODULADOR SELETIVO DO RECEPTOR DE ESTROGENO; OSTEOCLASTOS; CELULAS DENDRITICAS; MICROGLIA; MACROFAGOS ASSOCIADOS A TUMORES; CANCER DE MAMA; CANCER DE PROSTATA

31/48US=47 / Clín/Medica
Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G. Sex hormones and risk of liver tumor. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 228-36. ISBN 978-1-57331-699-5.

HORMONIOS SEXUAIS. RISCO DE TUMOR NO FIGADO; TUMORES BENIGNOS DO FIGADO; HCC; ESTROGENIOS; ANDROGENOS; AROMATASE

32/48US=47 / Clín/Medica
Hong Y, Chen S. Aromatase inhibitors: structural features and biochemical characterization. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 237-51. ISBN 978-1-57331-699-5.

INIBIDORES DA AROMATASE; CANCER DE MAMA; INIBIDORES DE AROMATASE; FLAVONOIDE FITOESTROGENO; INIBIDOR BASEADO NO MECANISMO; MODELO STRCTURAL

33/48US=47 / Clín/Medica
Di maio M, De Maio E, Morabito A, D'Aniello RD, De Feo G, Gallo C, Perrone F. Hormonal treatment of human hepatocellular carcinoma. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 252-61. ISBN 978-1-57331-699-5.

TRATAMENTO HORMONAL; CARCINOMA HEPATOCELULAR HUMANO; CARCINOMA HEPATOCELULAR; TAMOXIFEN

34/48US=47 / Clín/Medica
Granata OM, Cocciadiferro L Miceli V, Polito LM, Campisi I, Carruba G. Metabolic profiles of androgens in malignant human liver cell lines. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 262-7. ISBN 978-1-57331-699-5.

EST; ANDROGRENES 5X; ANDROGENES 5B; CELULAS HCC; METABOLICOS DE ANDROGENOS; CELULAS DE FIGADO HUMANO MALIGNO; LINHAS DE AROMATASE

35/48US=47 / Clín/Medica
Labbozzetta M, Notarbartolo M, Poma P, Giannitrapani L, Cervello M, Montalto G, D'Alessandro N. Significance of autologous interleukin-6 production in the HA22T/VGH cell model of hepatocellular carcinoma. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 268-75. ISBN 978-1-57331-699-5.

CARCINOMA HEPATOCELULAR; INTERLEUCINA-6; CIRCUITO ESTIMULANTE DO CRESCIMENTO CELULAR AUTOCRINE; NF-KB

36/48US=47 / Clín/Medica
Marotta F, ao GS, Liu T, Lorenzetti A, Xiao Y, Marandola P. Anti-inflammatory and neuroprotective effect of a phytoestrogen compound on rat microglia. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 276-81. ISBN 978-1-57331-699-5.

EFEITO ANTI-INFLAMATORIO; FITOESTROGENO; RATO MICROGLIA; NEUROPROTETOR; CITOCINAS

37/48US=47 / Clín/Medica
Yatrin E, Bernoulli J, Santti R. Activation of NF-kB in association with prostate carcinogenesis in noble rats. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 282-5. ISBN 978-1-57331-699-5.

INFLAMACAO; NF-KB; CARCINOGENESE DA PROSTATA

38/48US=47 / Clín/Medica
Cavalieri E, Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 286-301. ISBN 978-1-57331-699-5.

METABOLISMO DOS ESTROGENIOS; CATECOL QUINOSES; GENOTOXICIDADE DE ESTROGENOS; DEPURINATING ADUTOS DE DNA; MUTAGENICIDADE DE ESTROGENOS; BIOMARCADORES DE RISCO DE CANCER

39/48US=47 / Clín/Medica
Pozzi S, Benedusi V, Maggi A, Vegeto E. Estrogen action in neuroprotection and brain inflammation. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 302-23. ISBN 978-1-57331-699-5.

RECEPTORES DE ESTROGENO; INFLAMACAO; NEURODEGENERACAO

40/48US=47 / Clín/Medica
Xu H, Wang R, Zhang YW, Zhang X. Estrogen, B-amyloid metabolismo/trafficking, and Alzheimer's Disease. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 324-42. ISBN 978-1-57331-699-5.

ESTROGENIO; B-AMILOIDE; TRAFICO METABOLISMO; DOENCA DE ALZHEIMER

Primeira | Anterior | Próxima | Última